149 related articles for article (PubMed ID: 9171163)
1. Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors.
Alexander T; Sortwell CE; Sladek CD; Roth RH; Steece-Collier K
Cell Transplant; 1997; 6(3):309-15. PubMed ID: 9171163
[TBL] [Abstract][Full Text] [Related]
2. Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro.
Nakao N; Nakai K; Itakura T
Brain Res; 1997 Nov; 777(1-2):202-9. PubMed ID: 9449429
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity.
Blessing H; Bareiss M; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2003 Jan; 42(2):139-51. PubMed ID: 12421594
[TBL] [Abstract][Full Text] [Related]
4. Toxic effects of L-DOPA on mesencephalic cell cultures: protection with antioxidants.
Pardo B; Mena MA; Casarejos MJ; Paíno CL; De Yébenes JG
Brain Res; 1995 Jun; 682(1-2):133-43. PubMed ID: 7552304
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Takashima H; Tsujihata M; Kishikawa M; Freed WJ
Exp Neurol; 1999 Sep; 159(1):98-104. PubMed ID: 10486178
[TBL] [Abstract][Full Text] [Related]
6. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons.
Cheng N; Maeda T; Kume T; Kaneko S; Kochiyama H; Akaike A; Goshima Y; Misu Y
Brain Res; 1996 Dec; 743(1-2):278-83. PubMed ID: 9017256
[TBL] [Abstract][Full Text] [Related]
7. Glia conditioned medium protects fetal rat midbrain neurones in culture from L-DOPA toxicity.
Mena MA; Casarejos MJ; Carazo A; Paino CL; García de Yébenes J
Neuroreport; 1996 Jan; 7(2):441-5. PubMed ID: 8730801
[TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase inhibition attenuates levodopa toxicity in mesencephalic dopamine neurons.
Storch A; Blessing H; Bareiss M; Jankowski S; Ling ZD; Carvey P; Schwarz J
Mol Pharmacol; 2000 Mar; 57(3):589-94. PubMed ID: 10692500
[TBL] [Abstract][Full Text] [Related]
9. Calretinin-immunoreactive dopaminergic neurons from embryonic rat mesencephalon are resistant to levodopa-induced neurotoxicity.
Isaacs KR; Wolpoe ME; Jacobowitz DM
Exp Neurol; 1997 Jul; 146(1):25-32. PubMed ID: 9225735
[TBL] [Abstract][Full Text] [Related]
10. Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesions.
Datla KP; Blunt SB; Dexter DT
Mov Disord; 2001 May; 16(3):424-34. PubMed ID: 11391735
[TBL] [Abstract][Full Text] [Related]
11. Chronic levodopa impairs morphological development of grafted embryonic dopamine neurons.
Steece-Collier K; Collier TJ; Sladek CD; Sladek JR
Exp Neurol; 1990 Nov; 110(2):201-8. PubMed ID: 2226699
[TBL] [Abstract][Full Text] [Related]
12. Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress.
Mytilineou C; Walker RH; JnoBaptiste R; Olanow CW
J Pharmacol Exp Ther; 2003 Feb; 304(2):792-800. PubMed ID: 12538835
[TBL] [Abstract][Full Text] [Related]
13. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture.
Mena MA; Khan U; Togasaki DM; Sulzer D; Epstein CJ; Przedborski S
J Neurochem; 1997 Jul; 69(1):21-33. PubMed ID: 9202290
[TBL] [Abstract][Full Text] [Related]
14. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
Xu D; Karain B; Brantley E; Shi WX
J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359
[TBL] [Abstract][Full Text] [Related]
15. Activation of dopamine cell firing by repeated L-DOPA administration to dopamine-depleted rats: its potential role in mediating the therapeutic response to L-DOPA treatment.
Harden DG; Grace AA
J Neurosci; 1995 Sep; 15(9):6157-66. PubMed ID: 7666198
[TBL] [Abstract][Full Text] [Related]
16. Toxic and protective effects of L-dopa on mesencephalic cell cultures.
Mytilineou C; Han SK; Cohen G
J Neurochem; 1993 Oct; 61(4):1470-8. PubMed ID: 8376999
[TBL] [Abstract][Full Text] [Related]
17. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease.
Asanuma M; Miyazaki I; Ogawa N
Neurotox Res; 2003; 5(3):165-76. PubMed ID: 12835121
[TBL] [Abstract][Full Text] [Related]
18. Glia protect fetal midbrain dopamine neurons in culture from L-DOPA toxicity through multiple mechanisms.
Mena MA; Casarejos MJ; Carazo A; Paíno CL; García de Yébenes J
J Neural Transm (Vienna); 1997; 104(4-5):317-28. PubMed ID: 9295168
[TBL] [Abstract][Full Text] [Related]
19. Dual effects of L-DOPA on nigral dopaminergic neurons.
Guatteo E; Yee A; McKearney J; Cucchiaroni ML; Armogida M; Berretta N; Mercuri NB; Lipski J
Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
